An ultrasensitive high-throughput electrochemiluminescence immunoassay for the Cdc42-associated protein tyrosine kinase ACK1

Analytical Biochemistry

Volumn 367, Issue 2, 2007, Pages 179-189

  Xiao, Shou Hua ^a   Farrelly, Ellyn ^a   Anzola, John ^a   Crawford, Daniel ^a   Jiao, XianYun ^a   Liu, Jinqian ^a   Ayres, Merrill ^a   Li, Shyun ^a   Huang, Linda ^a   Sharma, Rajiv ^a   Kayser, Frank ^a   Wesche, Holger ^a   Young, Stephen W ^a  

^a AMGEN INC   (United States)

Author keywords

ACK1; BV tag; Cdc42 associated protein tyrosine kinase; Electrochemiluminescence assay; High throughput immunoassay; IC50; Ki; Ultrasensitive

Indexed keywords

AMINO ACIDS; IMMUNOLOGY; MONOCLONAL ANTIBODIES;

ACK1; BV-TAG; ELECTROCHEMILUMINESCENCE; HIGH THROUGHPUT; IC50; PROTEIN TYROSINE KINASE; ULTRA SENSITIVES;

ENZYMES;

MONOCLONAL ANTIBODY; PHOSPHOTYROSINE; PROTEIN CDC42; PROTEIN SERINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE ACK1; THREONINE; UNCLASSIFIED DRUG;

ARTICLE; CHEMOLUMINESCENCE; ELECTROIMMUNOASSAY; ENZYME MECHANISM; ENZYME PURIFICATION; HIGH THROUGHPUT SCREENING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 34347328253     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2007.05.007     Document Type: Article

References (28)

1. Cohen P. Protein kinases: The major drug targets of the twenty-first century?. Nat. Rev. Drug Discov. 21 (2002) 309-315
2. Wesche H., Xiao S.H., and Young S.W. High throughput screening for protein kinase inhibitors. Comb. Chem. High Throughput Screen 8 (2005) 181-195
3. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsannam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
4. Manser E., Leung T., Salihuddin H., Tan L., and Lim L. A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 363 (1993) 364-367
5. Yang W., and Cerione R.A. Cloning and characterization of a novel Cdc42-associated tyrosine kinase, ACK-2, from bovine brain. J. Biol. Chem. 272 (1997) 24819-24824
6. Kiyono M., Kato J., Kataoka T., Kaziro Y., and Satoh T. Stimulation of Ras guanine nucleotide exchange activity of Ras-GRF1/CDC25(Mm) upon tyrosine phosphorylation by the Cdc42-regulated kinase ACK1. J. Biol. Chem. 275 (2000) 29788-29793
7. Kato J., Kaziro Y., and Satoh T. Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation. Biochem. Biophys. Res. Commun. 268 (2000) 141-147
8. Eisenmann K.M., McCarthy J.B., Simpson M.A., Keely P.J., Guan J.L., Tachibana K., Lim L., Manser E., Furcht L.T., and Iida J. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1, and p130cas. Nat. Cell Biol. 1 (1999) 507-513
9. Yang W., Lo C.G., Dispenza T., and Cerione R.A. The Cdc42 target ACK2 directly interacts with clathrin and influences clathrin assembly. J. Biol. Chem. 276 (2001) 17468-17473
10. Coon M., and Herrera R. Modulation of HeLa cells spreading by the non-receptor tyrosine kinase ACK-2. J. Cell. Biochem. 84 (2002) 655-665
11. Nur-E-Kamal M.S., Kamal J.M., Qureshi M.M., and Maruta H. The CDC42-specific inhibitor derived from ACK-1 blocks v-Ha-Ras-induced transformation. Oncogene 18 (1999) 7787-7793
12. Teo M., Tan L., Lim L., and Manser E. The tyrosine kinase ACK1 associates with clathrin-coated vesicles through a binding motif shared by arrestin and other adaptors. J. Biol. Chem. 276 (2001) 18392-18398
13. Lin Q., Lo C.G., Cerione R.A., and Yang W. The Cdc42 target ACK2 interacts with sorting nexin 9 (SH3PX1) to regulate epidermal growth factor receptor degradation. J. Biol. Chem. 277 (2002) 10134-10138
14. Nur-E-Kamal A., Zhang A., Keenan S.M., Wang X.I., Seraj J., Satoh T., Meiners S., and Welsh W.J. Mol. Cancer Res. 3 (2005) 297-305
15. Mahajan N.P., Whang Y.E., Mohler J.L., and Earp H.S. Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: Role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res. 65 (2005) 10514-10523
16. van der Horst E.H., Degenhardt Y.Y., Strelow A., Slavin A., Chinn L., Orf J., Rong M., Li S., See L.H., Nguyen K.Q., Hoey T., Wesche H., and Powers S. Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc. Natl. Acad. Sci. USA 102 (2005) 15901-15906
17. Wu J.J. Comparison of SPA, FRET, and FP for kinase assays. In: Janzen W.P. (Ed). Methods in Molecular Biology. High Throughput Screening: Methods and Protocols 190 (2002), Humana, Totowa, NJ 65-85
18. Yokoyama N., and Miller W.T. Biochemical properties of the Cdc42-associated tyrosine kinase ACK1: Substrate specificity, autophosphorylation, and interaction with Hck. J. Biol. Chem. 278 (2003) 47713-47723
19. Golla R., and Seethala R. A sensitive, robust high-throughput electrochemiluminescence assay for rat insulin. J. Biomol. Screen. 9 (2004) 62-70
20. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
21. Morrison J.F. Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors. Biochim. Biophys. Acta 185 (1969) 269-286
22. Williams J.W., and Morrison J.F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 63 (1979) 437-467
23. Zhang J.H., Chung T.D., and Oldenburg K.R. Simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4 (1999) 67-73
24. Hanke J.H., Gardner J.P., Dow R.L., Changelian P.S., Brissette W.H., Weringer E.J., Pollok B.A., and Connelly P.A. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor: Study of Lck- and FynT-dependent T cell activation. J. Biol. Chem. 271 (1996) 695-701
25. Morrison J.F., and Walsh C.T. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61 (1988) 201-301
26. Kijek T.M., Rossi C.A., Moss D., Parker R.W., and Henchal E.A. Rapid and sensitive immunomagnetic-electrochemiluminescent detection of staphyloccocal enterotoxin B. J. Immunol. Methods 236 (2000) 9-17
27. Mao S.S., Colussi D., Bailey C.M., Bosserman M., Burlein C., Gardell S.J., and Carroll S.S. Electrochemiluminescence assay for basic carboxypeptidases: Inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor. Anal. Biochem. 319 (2003) 159-170
28. Schweitzer R.H., and Abriola L. Electrochemiluminescence: A technology evaluation and assay reformatting of the Sta6/P578 protein-protein interaction. In: Janzen W.P. (Ed). Methods in Molecular Biology. High Throughput Screening: Methods and Protocols 21 (2002), Humana, Totowa, NJ 87-106